Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Gross Profit of $5.14 million for fiscal year 2025.
NEUROONE MEDICAL TECHNOLOGIES Corp Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $5.14M | +376.2% |
| 2024 | $1.08M | +136.5% |
| 2023 | $456.5K | +744.9% |
| 2022 | -$70.8K | +27.6% |
| 2021 | -$97.7K | -10713.4% |
| 2012 | $921.00 | -71.7% |
| 2011 | $3.3K | +179.3% |
| 2010 | $1.2K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $1.57M | -18.6% | +71.4% |
| June 30, 2025 | $914.8K | +224.6% | +18.6% |
| March 31, 2025 | $771.1K | +97.5% | -60.0% |
| December 31, 2024 | $1.93M | +623.5% | +583.6% |
| June 30, 2024 | $281.9K | +15.7% | -27.8% |
| March 31, 2024 | $390.4K | +1139.3% | +46.6% |
| December 31, 2023 | $266.3K | +2263.9% | +9.3% |
| June 30, 2023 | $243.7K | +3899.6% | +673.5% |
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +376.2% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, NEUROONE MEDICAL TECHNOLOGIES Corp’s gross profit has grown by 440466.1% (from $1.2 thousand to $5.14 million).
- The most recent figure is from NEUROONE MEDICAL TECHNOLOGIES Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: